Previous 10 | Next 10 |
The following slide deck was published by Misonix, Inc. in conjunction with this event. For further details see: Misonix (MSON) Presents At UBS Global Healthcare Virtual Conference 2021 - Slideshow
FARMINGDALE, N.Y., May 14, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced it...
FARMINGDALE, N.Y., May 10, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that Chief Executive Officer, Stavros Vizirgianakis, along with...
Misonix, Inc. (MSON) Q3 2021 Earnings Conference Call May 06, 2021, 16:30 ET Company Participants Norberto Aja - JCIR Stavros Vizirgianakis - CEO & Director Joseph Dwyer - CFO, Treasurer & Secretary Conference Call Participants Alexander Nowak - Craig-Hallum Ryan Zimmerman - BTIG Pres...
MISONIX (MSON): FQ3 GAAP EPS of -$0.22 beats by $0.04.Revenue of $18.3M (+2.2% Y/Y) beats by $0.26M.Press Release For further details see: MISONIX EPS beats by $0.04, beats on revenue
FARMINGDALE, N.Y., May 06, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today reported financi...
FARMINGDALE, N.Y., April 20, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, announced today that it will report its fiscal 2021 third quarter financi...
FARMINGDALE, N.Y., March 30, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, announced today ...
The following slide deck was published by Misonix, Inc. in conjunction with this event. For further details see: Misonix (MSON) Investor Presenation - Slideshow
Misonix (MSON) announces that it has received a Health Canada license for its neXus Ultrasonic Surgical System.This approval confirms that neXus meets the requirements of Health Canada, allowing Misonix to commercialize neXus, along with its various handpieces and disposable product...
News, Short Squeeze, Breakout and More Instantly...
DURHAM, N.C. and FARMINGDALE, N.Y., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, and Misonix, Inc. (Nasdaq: MSON) (“Misonix”), a provider of...
DURHAM, N.C. and FARMINGDALE, N.Y., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) and Misonix, Inc . (Nasdaq: MSON) (“Misonix”), today announced an election deadline of 5:00 p.m., New York City Time, on October 25, 2021 (the “Election Deadline...
FARMINGDALE, N.Y., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today reported unaud...